Fermenta Biotech [FERMENTA] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Fermenta Biotech

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech wins in 10 metrics, Suven Life Sciences wins in 8 metrics, with 0 ties. Fermenta Biotech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFermenta BiotechSuven Life SciencesBetter
P/E Ratio (TTM)9.13-28.31Suven Life Sciences
Price-to-Book Ratio2.6641.36Fermenta Biotech
Debt-to-Equity Ratio32.060.00Suven Life Sciences
PEG Ratio-0.02-0.34Suven Life Sciences
EV/EBITDA7.12-24.12Suven Life Sciences
Profit Margin (TTM)19.81%84.44%Suven Life Sciences
Operating Margin (TTM)16.45%-2,791.92%Fermenta Biotech
EBITDA Margin (TTM)16.45%N/AN/A
Return on Equity21.44%-146.15%Fermenta Biotech
Return on Assets (TTM)12.51%-118.91%Fermenta Biotech
Free Cash Flow (TTM)$187.69M$-1.91BFermenta Biotech
Dividend Yield0.71%N/AN/A
1-Year Return2.71%49.21%Suven Life Sciences
Price-to-Sales Ratio (TTM)1.81632.35Fermenta Biotech
Enterprise Value$10.03B$44.90BSuven Life Sciences
EV/Revenue Ratio1.90597.31Fermenta Biotech
Gross Profit Margin (TTM)65.48%100.00%Suven Life Sciences
Revenue per Share (TTM)$181$0Fermenta Biotech
Earnings per Share (Diluted)$35.83$-8.45Fermenta Biotech
Beta (Stock Volatility)-0.160.78Fermenta Biotech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fermenta Biotech vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Fermenta Biotech
Suven Life Sciences
Fermenta Biotech Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech-4.24%0.34%-8.40%-1.87%23.06%-17.75%
Suven Life Sciences-2.18%3.79%-10.27%-21.82%76.25%63.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech2.71%61.94%-8.27%70.06%70.06%70.06%
Suven Life Sciences49.21%215.69%329.98%-26.12%600.33%3,806.72%

News Based Sentiment: Fermenta Biotech vs Suven Life Sciences

Fermenta Biotech

News based Sentiment: POSITIVE

Fermenta Biotech’s Q3 FY24 results demonstrate significant revenue and profit growth, driven by its Vitamin D3 business. The company’s commitment to sustainability further enhances its long-term investment appeal, making this a noteworthy month for investors.

View Fermenta Biotech News Sentiment Analysis

Suven Life Sciences

News based Sentiment: MIXED

October was a month of conflicting signals for Suven Life Sciences. While the company benefited from a positive pharmaceutical sector rally and maintained a debt-free status, it also reported continued quarterly losses and received a negative analyst rating. This creates a complex investment narrative with both potential opportunities and significant risks.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Fermenta Biotech vs Suven Life Sciences

MetricFERMENTASUVEN
Market Information
Market Cap i₹9.82B₹47.99B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i24,185184,111
90 Day Avg. Volume i29,849150,383
Last Close₹308.45₹204.83
52 Week Range₹219.00 - ₹449.00₹102.50 - ₹299.99
% from 52W High-31.30%-31.72%
All-Time High₹449.00 (Feb 10, 2025)₹338.50 (Apr 13, 2015)
% from All-Time High-31.30%-39.49%
Growth Metrics
Quarterly Revenue Growth0.74%0.86%
Quarterly Earnings Growth0.74%0.86%
Financial Health
Profit Margin (TTM) i0.20%0.84%
Operating Margin (TTM) i0.16%-27.92%
Return on Equity (TTM) i0.21%-1.46%
Debt to Equity (MRQ) i32.060.00
Cash & Liquidity
Book Value per Share (MRQ)₹123.23₹5.04
Cash per Share (MRQ)₹24.01₹2.75
Operating Cash Flow (TTM) i₹-59,490,000₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹768.62M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i0.71%N/A
Last 12-Month Dividend i₹2.50₹0.00

Valuation & Enterprise Metrics Analysis: Fermenta Biotech vs Suven Life Sciences

MetricFERMENTASUVEN
Price Ratios
P/E Ratio (TTM) i9.13-28.31
Forward P/E iN/A10.78
PEG Ratio i-0.02-0.34
Price to Sales (TTM) i1.81632.35
Price to Book (MRQ) i2.6641.36
Market Capitalization
Market Capitalization i₹9.82B₹47.99B
Enterprise Value i₹10.03B₹44.90B
Enterprise Value Metrics
Enterprise to Revenue i1.90597.31
Enterprise to EBITDA i7.12-24.12
Risk & Other Metrics
Beta i-0.160.78
Book Value per Share (MRQ) i₹123.23₹5.04

Financial Statements Comparison: Fermenta Biotech vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FERMENTASUVEN
Revenue/Sales i₹1.36B₹18.67M
Cost of Goods Sold i₹470.43M₹0
Gross Profit i₹892.20M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹224.21M₹-521.17M
EBITDA i₹370.04M₹-501.49M
Pre-Tax Income i₹280.87M₹-515.17M
Income Tax i₹64.85M₹0
Net Income (Profit) i₹216.02M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FERMENTASUVEN
Cash & Equivalents i₹282.40M₹150.26M
Total Current Assets i₹3.35B₹754.72M
Total Current Liabilities i₹2.12B₹234.86M
Long-Term Debt i₹194.91MN/A
Total Shareholders Equity i₹3.59B₹1.10B
Retained Earnings i₹3.25B₹-6.01B
Property, Plant & Equipment i₹2.16B₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FERMENTASUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFERMENTASUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i24,185184,111
Average Daily Volume (90 Day) i29,849150,383
Shares Outstanding i29.17M218.07M
Float Shares i8.54M67.61M
% Held by Insiders i0.70%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Fermenta Biotech vs Suven Life Sciences

MetricFERMENTASUVEN
Last 12-Month Dividend i₹2.50₹0.00
Last 12-Month Dividend Yield i0.71%N/A
3-Year Avg Annual Dividend i₹0.83₹0.00
3-Year Avg Dividend Yield i0.71%N/A
3-Year Total Dividends i₹2.50₹0.00
Ex-Dividend DateAug 06, 2025N/A